Aluminium

Overview

According to the document, aluminium is a heavy metal acquired primarily through environmental exposure, entering the body through food, water, medicines, skin absorption, and inhalation (page 2). It is commonly found in antacids, phosphate binders, food additives, vaccines, solvents, paints, and polluted air, soil, or water. Patients with metallic joint prostheses made from aluminium, vanadium, and titanium may also show higher serum aluminium levels.

Under normal conditions, aluminium is excreted through urine. However, long-term or repeated exposure reduces the body’s ability to eliminate it effectively, leading to accumulation. Excess aluminium—above 5–10 mg—is toxic and harmful to both the brain and bones (page 3). Aluminium rapidly enters brain tissue, extracellular fluid, and cerebrospinal fluid. The document associates its buildup with neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis.

Bone calcium becomes unavailable for physiological resorption, contributing to secondary hyperparathyroidism. The test for aluminium is a quantitative blood analysis (page 6) used to diagnose heavy metal toxicity and to monitor aluminium buildup in patients with renal failure or neurodegenerative disorders.

Symptoms

Symptoms arise from aluminium accumulation affecting neurological, skeletal, hematological, and muscular systems. According to the document (pages 14–15), major symptoms include:

Neurological Symptoms

1. Confusion and memory loss
2. Speech difficulties
3. Fits and seizures
4. Encephalopathy and nervous system disorders
5. These arise from aluminium deposition in brain tissue and cerebrospinal fluid.

Musculoskeletal Symptoms

1. Muscle weakness
2. Bone pain
3. Frequent fractures
4. Proximal myopathy
5. These signs reflect aluminium’s interference with bone metabolism and calcium regulation.

Blood and Systemic Symptoms

1. Microcytic anemia due to impaired iron absorption
2. Slow growth in children
3. Increased risk of infection
4. Cardiac effects such as increased left ventricular mass and decreased myocardial function

In severe cases, the document notes that very high aluminium levels may lead to sudden death.

Causes

The document clearly outlines common routes and mechanisms that lead to aluminium toxicity.

Environmental & Occupational Exposure

(Page 4)

1. Mining, smelting
2. Exposure through soil or water contamination
3. Industrial fumes or dust inhalation

Medical & Dietary Sources

(Page 2 & 4)

1. Antacids and phosphate binders
2. Parenteral nutrition solutions
3. Dialysis fluids
4. Vaccines containing aluminium
5. Cookware and food additives

Impaired Excretion

(Page 3)

Kidney dysfunction reduces aluminium elimination, causing greater accumulation over time.

Prosthetic Devices

(Page 2)

Metallic implants containing aluminium can release trace amounts into the bloodstream.

Chelation & Contamination Issues

(Page 19)

1. Post-chelation samples may give misleading results
2. Use of aluminium containers or powder-coated gloves may contaminate specimens

Risk Factors

The document (page 7) lists several groups at higher risk of toxic aluminium buildup:

1. Occupational Exposure

People working in industrial environments such as smelting, mining, or manufacturing have increased inhalation and ingestion risk.

2. Dialysis & Renal Failure Patients

Individuals with chronic renal failure (CRF) on dialysis are unable to clear aluminium effectively.

3. Patients on Parenteral Nutrition or Intravenous Albumin

These medical solutions may contain aluminium.

4. Infants & Adults Receiving Aluminium-Containing Medications

Frequent intake of antacids or phosphate binders increases susceptibility.

5. Neurodegenerative Disorders

Patients with existing brain disorders may accumulate aluminium more quickly.

6. Hyperparathyroidism & Unexplained Bone Disease

These conditions worsen aluminium’s harmful skeletal effects.

7. Those Exposed to Contaminated Dialysate

Document emphasizes the importance of monitoring dialysate for aluminium contamination.

Prevention

Prevention focuses on minimizing exposure, avoiding contamination, and ensuring accurate laboratory measurement.

1. Avoid Aluminium-Containing Products Before Testing

(Page 8)

Patients should avoid antacids, supplements, vitamins, minerals, and unnecessary medications that may affect results.

2. Use Correct Sample Collection Techniques

(Page 9 & 19)

1. Collect 6 mL of blood in a plain (red) or EDTA (lavender) tube.
2. Separate serum or plasma promptly.
3. Ensure no aluminium contamination from containers or gloves.

3. Monitor High-Risk Patients

Regular aluminium testing in:

1. Dialysis patients
2. Those receiving long-term parenteral nutrition
3. Patients with unexplained neurological or bone symptoms

4. Control Environmental & Occupational Exposure

Using safety equipment, improving ventilation, and minimizing inhalation of industrial dust help reduce risk.

5. Evaluate Dialysis Fluids

(Page 7)

Dialysate should be monitored to avoid aluminium accumulation in renal patients.